Universal primer set for the full-length amplification of all influenza A viruses
about
Full genomic analysis of an influenza A (H1N2) virus identified during 2009 pandemic in Eastern India: evidence of reassortment event between co-circulating A(H1N1)pdm09 and A/Brisbane/10/2007-like H3N2 strainsSerum amyloid P is a sialylated glycoprotein inhibitor of influenza A virusesAvian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndromeIdentification of H2N3 influenza A viruses from swine in the United StatesA novel nonhuman primate model for influenza transmissionEffect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferretsEvidence for a Novel Mechanism of Influenza Virus-Induced Type I Interferon Expression by a Defective RNA-Encoded ProteinSpatial dynamics of human-origin H1 influenza A virus in North American swineAcute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptidesIsolation of H5N6, H7N9 and H9N2 avian influenza A viruses from air sampled at live poultry markets in China, 2014 and 2015High-throughput RNA sequencing of a formalin-fixed, paraffin-embedded autopsy lung tissue sample from the 1918 influenza pandemicInfluenza aerosols in UK hospitals during the H1N1 (2009) pandemic--the risk of aerosol generation during medical proceduresPathogenicity of reassortant H9 influenza viruses with different NA genes in mice and chickensOseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferretsOseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferretsCyclosporin A inhibits the influenza virus replication through cyclophilin A-dependent and -independent pathwaysResistance mutation R292K is induced in influenza A(H6N2) virus by exposure of infected mallards to low levels of oseltamivirProspective surveillance and molecular characterization of seasonal influenza in a university cohort in SingaporeCharacterization of a novel mutation in NS1 protein of influenza A virus induced by a chemical substance for the attenuation of pathogenicitySensitive Detection and Simultaneous Discrimination of Influenza A and B Viruses in Nasopharyngeal Swabs in a Single Assay Using Next-Generation Sequencing-Based DiagnosticsA new reassortment of influenza A (H7N9) virus causing human infection in Beijing, 2014Airborne transmission of influenza A/H5N1 virus between ferretsMolecular Evidence of Transmission of Influenza A/H1N1 2009 on a University Campus.Influenza a virus migration and persistence in North American wild birds.Chinese and global distribution of H9 subtype avian influenza viruses.Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in AsiaThe viral polymerase mediates adaptation of an avian influenza virus to a mammalian host.The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04.Avian influenza: virology, diagnosis and surveillance.The first detection of influenza in the Finnish pig population: a retrospective study.Molecular evolution of the hemagglutinin and neuraminidase genes of pandemic (H1N1) 2009 influenza viruses in Sendai, Japan, during 2009-2011.Swine influenza: clinical, serological, pathological, and virological cross-sectional studies in nine farms in Argentina.A novel reassortant H1N2 virus related to the pandemic H1N1 2009 influenza virus isolated from Korean pigs.Avian influenza virus h3 hemagglutinin may enable high fitness of novel human virus reassortantsDifferent evolutionary trends of swine H1N2 influenza viruses in Italy compared to European viruses.Outbreak of H3N2 influenza at a US military base in Djibouti during the H1N1 pandemic of 2009.Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.Potency of an inactivated influenza vaccine prepared from A/duck/Hong Kong/960/1980 (H6N2) against a challenge with A/duck/Vietnam/OIE-0033/2012 (H6N2) in mice.H3N2 canine influenza virus with the matrix gene from the pandemic A/H1N1 virus: infection dynamics in dogs and ferrets.Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.
P2860
Q21245092-242D05D9-9E6E-4BF1-B8D2-D78D0B957DEBQ24337745-EF8C2E29-D628-40C0-9D45-C9DCC0C410F4Q24608173-000AB5EA-1AF5-4ACD-A396-2C5036AD4A94Q24646263-EC2AC939-BE11-40E7-81D2-3F6599FE4B51Q27302967-2B3C9C49-2627-423D-BB7E-969855951BE9Q27314689-CEA47FC8-6E63-4796-8F56-4F396D3F54CDQ27319771-900E681C-11D1-49EB-A10F-8834DD8814A9Q27349761-96C75C41-5B2D-466A-BA9D-0B5FD48A97D7Q27687391-92F5650E-B45B-4034-89D8-52CC3A8114F6Q27908638-AE57AF2E-BFAE-443E-BAC1-8FD8777877D8Q28279911-9A7BA291-C39C-4CE6-90A2-0898205DA7DDQ28394356-1660A842-0165-4BE4-B659-70A383B6C90AQ28397693-7B16EE3C-EC78-40A2-819B-B524F0EF7776Q28474889-3C4A2615-B61F-4345-8A16-095385C34422Q28474960-FEBF64B4-7CBD-4F04-B580-8B3082E89586Q28483731-F0E0E862-2CC0-4A08-9BF6-FB50BAD4D8AFQ28535274-44D5856F-85A7-4E27-9076-099D76F6C384Q28539676-69DB746E-5418-461F-A068-2BFFA766677DQ28544812-2F5A964A-F316-47D5-BA99-9752B239F44FQ28554325-BBD72F1E-B1A9-4BE6-89E9-8636F3A7F6C1Q28602120-1E93BF47-F274-460E-9442-96F99A788778Q29619970-8EACE2D8-0F5E-4738-9ADD-4D928AEC8E93Q30151482-9210631F-3A00-4F06-92C6-4F3AC05A66DBQ30220802-970CDF06-7298-429B-9F42-A62A2A8FEAB0Q30223521-0B1CBF3A-2BFC-4352-8ECC-AC50FE7156D4Q30351075-85E712D0-B0FE-47CC-AC0B-D447B321263FQ30352150-D9FCD856-B6A8-409C-B354-CB2612F54BB8Q30353368-95B157D4-E709-497E-9065-D7DD919D8A0CQ30353483-F8DDE0EE-0A62-44D0-93D9-EFE7A188A811Q30353706-5AAB4794-4E17-4F89-A831-5002C06E9B6BQ30354016-E96268AB-0728-45F8-BCFB-4749916DB513Q30355541-E1CC678F-2F5D-416C-B845-B7678BA35CE3Q30355731-B674FF69-6E03-4DF2-AE11-2E4B0E2B1349Q30355903-71814297-9B21-4243-A521-046D67EC5996Q30356196-3762268D-A86D-4232-8434-091B0D637E0DQ30356870-E0700137-2A41-4EC3-9914-C9829E2C2970Q30359013-2EC81987-6E12-4140-9FAE-0ED3A93D437FQ30362515-EA049DBA-567C-4C4C-BF62-5F834B37C2E7Q30364146-1AC7F488-7FC5-4EAC-82B5-6A405B8C35EDQ30365079-73353E93-BF9A-4444-A8FC-08849887794E
P2860
Universal primer set for the full-length amplification of all influenza A viruses
description
im Dezember 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 December 2001
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2001
@uk
name
Universal primer set for the full-length amplification of all influenza A viruses
@en
Universal primer set for the full-length amplification of all influenza A viruses
@nl
type
label
Universal primer set for the full-length amplification of all influenza A viruses
@en
Universal primer set for the full-length amplification of all influenza A viruses
@nl
prefLabel
Universal primer set for the full-length amplification of all influenza A viruses
@en
Universal primer set for the full-length amplification of all influenza A viruses
@nl
P50
P356
P1433
P1476
Universal primer set for the full-length amplification of all influenza A viruses
@en
P2093
E Hoffmann
P2888
P304
P356
10.1007/S007050170002
P577
2001-12-01T00:00:00Z